Patent details

EP2657234 Title: OPTICALLY-ACTIVE DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR MANUFACTURING SAME

Basic Information

Publication number:
EP2657234
PCT Application Number:
PCT/JP/2011/065001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118505858
PCT Publication Number:
WO/2012/086241
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
OPTICALLY-ACTIVE DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR MANUFACTURING SAME
French Title of Invention:
DÉRIVÉ DE DIAZABICYCLOOCTANE OPTIQUEMENT ACTIF ET PROCÉDÉ DE FABRICATION DE CELUI-CI
German Title of Invention:
OPTISCH AKTIVES DIAZABICYCLOOKTANDERIVAT UND VERFAHREN ZU SEINER HERSTELLUNG
SPC Number:

Dates

Filing date:
30/06/2011
Grant date:
11/01/2017
EP Publication Date:
11/01/2017
PCT Publication Date:
28/06/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/10/2013
EP B1 Publication Date:
11/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/06/2017
Expiration date:
30/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/06/2011
 
 

Name:
Meiji Seika Pharma Co. Ltd.
Address:
4-16, Kyobashi 2-chome Chuo-ku, Tokyo 104-8002, Japan (JP)

Inventor

1

Name:
OKUE Masayuki
Address:
Japan (JP)

2

Name:
SAKAMAKI Yoshiaki
Address:
Japan (JP)

3

Name:
ABE Takao
Address:
Japan (JP)

Priority

Priority Number:
0/073093
Priority Date:
22/12/2010
Priority Country:
Japan (JP)

Classification

Main IPC Class:
C07D 471/08;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages